V029-4364 Screening compound: 3-phenyl-N-(2-phenylethyl)-N-{2-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]ethyl}propanamide

V029-4364 Screening compound: 3-phenyl-N-(2-phenylethyl)-N-{2-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]ethyl}propanamide
V029-4364 Screening compound: 3-phenyl-N-(2-phenylethyl)-N-{2-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]ethyl}propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-4364
3-phenyl-N-(2-phenylethyl)-N-{2-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]ethyl}propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-4364

Molecular Formula

C26H26N4O2 (C26 H26 N4 O2)

Compound Name

3-phenyl-N-(2-phenylethyl)-N-{2-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]ethyl}propanamide

IUPAC name

3-phenyl-N-(2-phenylethyl)-N-{2-[3-(pyridin-4-yl)-124-oxadiazol-5-yl]ethyl}propanamide

SMILES

O=C(CCc1ccccc1)N(CCc1nc(-c2ccncc2)no1)CCc1ccccc1

InChI

InChI=1S/C26H26N4O2/c31-25(12-11-21-7-3-1-4-8-21)30(19-15-22-9-5-2-6-10-22)20-16-24-28-26(29-32-24)23-13-17-27-18-14-23/h1-10,13-14,17-18H,11-12,15-16,19-20H2

InChI Key

XJWNMZFQLPJNKL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19778092

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

426.52

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.378

Distribution Coefficient, logD

4.378

Water Solubility, LogSw

-4.22

Polar Surface Area

56.379

Acid Dissociation Constant (pKa)

22.71

Base Dissociation Constant (pKb)

3.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.10

V029-4364 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V029-4364 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-4364?
Check Price and Availability of V029-4364, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-4364 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-4364
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-4364
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-4364 available by request